当前位置: X-MOL 学术Am. J. Clin. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Stereotactic Body Radiotherapy for Palliation of Hematuria Arising From Urothelial Carcinoma of the Kidney in Unfavorable Surgical Candidates.
American Journal of Clinical Oncology ( IF 2.6 ) Pub Date : 2021-03-12 , DOI: 10.1097/coc.0000000000000801
Jesse Aronowitz 1 , Linda Ding 1 , Jennifer Yates 2 , Yang Zong 3 , Larry Zheng 4 , Zhong Jiang 3 , Jessica Yancey 5 , Kriti Mittal 6 , Thomas J Fitzgerald 1
Affiliation  

Hematuria can be a distressing and debilitating complication of urothelial carcinoma (UC) of the kidney for patients who are not candidates for surgery or ureteroscopic ablation. We retrospectively assessed the efficacy, tolerability, and safety of stereotactic body radiotherapy (SBRT) for controlling gross hematuria in this patient population.

中文翻译:

立体定向全身放射治疗可缓解不适合手术的肾尿路上皮癌引起的血尿。

对于不适合手术或输尿管镜消融术的患者来说,血尿可能是肾尿路上皮癌 (UC) 的一种令人痛苦且令人衰弱的并发症。我们回顾性评估了立体定向放射治疗 (SBRT) 控制该患者群体肉眼血尿的有效性、耐受性和安全性。
更新日期:2021-03-16
down
wechat
bug